Fig. 1 · Structure
Documents & Downloads
KM02894
Glutamate Release Inhibitor
KM02894 is a potent inhibitor of glutamate release, demonstrating its capacity to downregulate excess glutamate levels associated with cancer cells. By inhibiting glutamate secretion, KM02894 may mitigate disruptions in normal bone turnover and help address cancer-induced bone pain. This compound is valuable for research applications focusing on cancer biology and the development of therapeutic strategies targeting cancer-related bone disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 116850-74-9 |
| Applications | Glutamate Release Inhibitor |
| Formula | C7H9N3OS2 |
| Molecular Weight | 215.30 |
| SMILES | CNC(NNC(C1=CC=CS1)=O)=S |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.